Mayne Pharma: Winner

Submitted by Marco on 23 September, 2006 - 17:43

Mayne Pharma (MYP) Stock Price Chart

Mayne Pharma (MYP) jumped 44 percent this week making them the best performing stock on the ASX this week (Winner of the week for week 38). The pharmaceuticals company saw a bid this week and the stock closed the week trading at a premium over the $4.10 share takeover price announced by the takeover group.

Mayne Pharma Limited is listed on the Australian Stock Exchange (ASX) under stock code MYP. You can view their investor website here. Mayne pharma is focused on providing a full range of pharmaceutical solutions to oncologists. Their portfolio has been built around deep scientific and manufacturing expertise in two key pillars of anti-cancer treatments today: taxane derived pharmaceuticals and platinums. Over 70% of sales revenue in its 2005 financial year was derived from the northern hemisphere. The company was listed on the ASX on 21 November, 2005. MYP conducts an international pharmaceuticals business focused on the research and development, manufacture, marketing and distribution of injectable generic and specialty pharmaceuticals. Mayne pharma is focused on providing a full range of pharmaceutical solutions to oncologists. Their portfolio has been built around deep scientific and manufacturing expertise in two key pillars of anti-cancer treatments today: taxane derived pharmaceuticals and platinums. Over 70% of sales revenue in its 2005 financial year was derived from the northern hemisphere. Browse for Australian stockbroker recommendations. Check your charts and good luck with your share trading!

Download our FREE App


Signup for Free
Don't miss out on your free share trading articles.


Free Risk Money Management Calculator for those who sign up!